The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novavax Inc | 2.94 | 209.6 Mil | Healthcare |
Insmed Inc | 2.36 | 168.1 Mil | Healthcare |
Moderna Inc | 1.50 | 107.0 Mil | Healthcare |
Twist Bioscience Corp | 1.48 | 105.1 Mil | Healthcare |
Geron Corp | 1.37 | 97.4 Mil | Healthcare |
Dyne Therapeutics Inc Ordinary Shares | 1.35 | 96.0 Mil | Healthcare |
Natera Inc | 1.33 | 94.4 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.31 | 93.5 Mil | Healthcare |
Halozyme Therapeutics Inc | 1.27 | 90.2 Mil | Healthcare |
PTC Therapeutics Inc | 1.26 | 89.9 Mil | Healthcare |